{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,26]],"date-time":"2025-08-26T06:41:35Z","timestamp":1756190495011,"version":"3.37.3"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T00:00:00Z","timestamp":1658707200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"South Egypt Cancer Institute"},{"DOI":"10.13039\/501100009169","name":"Assiut University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100009169","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Leukemia patients are immune-compromised even before starting chemotherapy because the malignant cells invade the bone marrow and destroy WBC precursors. Leukemic patients are more susceptible to infection by a wide range of microorganisms. Viral infections and reactivations are common and may result in severe complications. The aim of this study is to investigate different causes of viremia in ALL pediatric patients as well as the clinical and the laboratory characteristics associated with viral infections.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Qualitative real-time PCR was used to detect (polyoma BK, parvo B19 and herpes simplex virus) DNA in the blood of ALL patients and routine hospital records were used to provide the data of hepatitis B &amp; C virus infection.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Polyoma BK was the most common detected virus (51.2%) followed by herpes simplex (30.2%)<jats:bold>.<\/jats:bold> Viremia by single virus was found in 16 (37.2%) cases, while viremia by multiple viruses was found in 15 (34.8%) cases<jats:bold>.<\/jats:bold> The most frequent co-detected viruses were herpes simplex and polyoma BK (11.6%) followed by herpes simplex, parvo B19 and polyoma BK (9.3%)<jats:bold>.<\/jats:bold><\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>There is a high frequency of viremia by single virus and viremia by multiple viruses at the time of diagnosis of acute lymphoblastic leukemia in pediatric patients admitted to South Egypt Cancer Institute (SECI) compared to studies in other regions. Polyoma BK is the most common detected virus and is mainly associated with lymphopenia. It was also significantly associated with herpes simplex viremia. HCV infection was associated with increased incidence of CNS leukemia.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s15010-022-01878-9","type":"journal-article","created":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T11:03:56Z","timestamp":1658747036000},"page":"203-211","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Investigating causes and risk factors of pre-chemotherapy viremia in acute lymphoblastic leukemia pediatric patients"],"prefix":"10.1007","volume":"51","author":[{"given":"Nivin","family":"Abdel-azim","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3356-9119","authenticated-orcid":false,"given":"Lamiaa Fadel","family":"Alkilany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zeinab Korany","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noha","family":"Gaber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,25]]},"reference":[{"key":"1878_CR1","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1056\/NEJM199506153322407","volume":"332","author":"C-H Pui","year":"1995","unstructured":"Pui C-H. Childhood leukemias. N Engl J Med. 1995;332:1618\u201330.","journal-title":"N Engl J Med"},{"key":"1878_CR2","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a034835","volume":"10","author":"KG Roberts","year":"2020","unstructured":"Roberts KG, Mullighan CG. The biology of B-progenitor acute lymphoblastic leukemia. Cold Spring Harb Perspect Med. 2020;10: a034835.","journal-title":"Cold Spring Harb Perspect Med"},{"key":"1878_CR3","doi-asserted-by":"publisher","first-page":"177","DOI":"10.3389\/fcimb.2018.00177","volume":"8","author":"S Sehrawat","year":"2018","unstructured":"Sehrawat S, Kumar D, Rouse BT. Herpesviruses: harmonious pathogens but relevant cofactors in other diseases? Front Cell Infect Microbiol. 2018;8:177.","journal-title":"Front Cell Infect Microbiol"},{"key":"1878_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.transproceed.2010.07.027","author":"E Jaskula","year":"2010","unstructured":"Jaskula E, et al. Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation. Transplant Proc. 2010. https:\/\/doi.org\/10.1016\/j.transproceed.2010.07.027.","journal-title":"Transplant Proc"},{"key":"1878_CR5","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(00)04638-9","volume":"357","author":"RJ Whitley","year":"2001","unstructured":"Whitley RJ, Roizman B. Herpes simplex virus infections. The Lancet. 2001;357:1513\u20138.","journal-title":"The Lancet"},{"key":"1878_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2013\/373579","volume":"2013","author":"CF De Gascun","year":"2013","unstructured":"De Gascun CF, Carr MJ. Human polyomavirus reactivation: disease pathogenesis and treatment approaches. Clin Dev Immunol. 2013;2013: 373579.","journal-title":"Clin Dev Immunol"},{"key":"1878_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1002\/(SICI)1096-911X(199808)31:2<66::AID-MPO4>3.0.CO;2-X","volume":"31","author":"K Broliden","year":"1998","unstructured":"Broliden K, et al. Persistent B19 parvovirus infection in pediatric malignancies. Med Pediatr Oncol. 1998;31:66\u201372.","journal-title":"Med Pediatr Oncol"},{"key":"1878_CR8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/rmv.322","volume":"11","author":"L Xunrong","year":"2001","unstructured":"Xunrong L, et al. Hepatitis B virus (HBV) reactivation after cytotoxic or immunosuppressive therapy\u2014pathogenesis and management. Rev Med Virol. 2001;11:287\u201399.","journal-title":"Rev Med Virol"},{"key":"1878_CR9","first-page":"33","volume":"15","author":"A Mostafa","year":"2003","unstructured":"Mostafa A, et al. Seroprevalence of hepatitis B and C in pediatric malignancies. J Egypt Natl Canc Inst. 2003;15:33\u201342.","journal-title":"J Egypt Natl Canc Inst"},{"key":"1878_CR10","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1056\/NEJMsr1912628","volume":"382","author":"I Waked","year":"2020","unstructured":"Waked I, et al. Screening and treatment program to eliminate hepatitis C in Egypt. N Engl J Med. 2020;382:1166\u201374.","journal-title":"N Engl J Med"},{"key":"1878_CR11","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1086\/421559","volume":"39","author":"G Gavazzi","year":"2004","unstructured":"Gavazzi G, Herrmann F, Krause K-H. Aging and infectious diseases in the developing world. Clin Infect Dis. 2004;39:83\u201391.","journal-title":"Clin Infect Dis"},{"key":"1878_CR12","doi-asserted-by":"crossref","unstructured":"Tsunemine H et al. Multiplex polymerase chain reaction assay for early diagnosis of viral infection. Polymerase Chain Reaction for Biomedical Applications, 2016","DOI":"10.5772\/65771"},{"key":"1878_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12985-020-01302-4","volume":"17","author":"I Handous","year":"2020","unstructured":"Handous I, et al. Co-infections of human herpesviruses (CMV, HHV-6, HHV-7 and EBV) in non-transplant acute leukemia patients undergoing chemotherapy. Virol J. 2020;17:1\u201315.","journal-title":"Virol J"},{"key":"1878_CR14","first-page":"9","volume":"1","author":"MH Maher","year":"2018","unstructured":"Maher MH, et al. HCMV among pediatrics acute lymphoblastic leukemia patients in South Egypt Cancer Institute. Age. 2018;1:9.","journal-title":"Age"},{"key":"1878_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.bjid.2019.01.005","volume":"23","author":"MF Haghighi","year":"2019","unstructured":"Haghighi MF, et al. Polyomaviruses BK and JC DNA infection in peripheral blood cells from blood donors. Brazilian J Infect Dis. 2019;23:22\u20136.","journal-title":"Brazilian J Infect Dis"},{"key":"1878_CR16","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.jiph.2016.01.008","volume":"10","author":"SA Loutfy","year":"2017","unstructured":"Loutfy SA, et al. Polyomavirus infections and its clinical relevance in cancer patients: a prospective study. J Infect Public Health. 2017;10:22\u201330.","journal-title":"J Infect Public Health"},{"key":"1878_CR17","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s12253-010-9258-6","volume":"16","author":"SB Mahjour","year":"2010","unstructured":"Mahjour SB, et al. Seroprevalence of human herpes simplex, hepatitis B and epstein-barr viruses in children with acute lymphoblastic leukemia in southern Iran. Pathol Oncol Res. 2010;16:579\u201382.","journal-title":"Pathol Oncol Res"},{"key":"1878_CR18","first-page":"1139","volume":"27","author":"SA Loutfy","year":"2006","unstructured":"Loutfy SA, et al. Seroprevalence of herpes simplex virus types 1 and 2, Epstein-Barr virus, and cytomegalovirus in children with acute lymphoblastic leukemia in Egypt. Saudi Med J. 2006;27:1139.","journal-title":"Saudi Med J"},{"key":"1878_CR19","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1086\/526522","volume":"46","author":"A Lindblom","year":"2008","unstructured":"Lindblom A, et al. Parvovirus B19 infection in children with acute lymphoblastic leukemia is associated with cytopenia resulting in prolonged interruptions of chemotherapy. Clin Infect Dis. 2008;46:528\u201336.","journal-title":"Clin Infect Dis"},{"key":"1878_CR20","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1751-553X.2009.01150.x","volume":"32","author":"MES Zaki","year":"2010","unstructured":"Zaki MES, Ashray RE. Clinical and hematological study for parvovirus B19 infection in children with acute leukemia. Int J Lab Hematol. 2010;32:159\u201366.","journal-title":"Int J Lab Hematol"},{"key":"1878_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-017-17936-4","volume":"8","author":"SP Kouyoumjian","year":"2018","unstructured":"Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci Rep. 2018;8:1\u201317.","journal-title":"Sci Rep"},{"key":"1878_CR22","doi-asserted-by":"publisher","first-page":"662","DOI":"10.21608\/ejhm.2020.93891","volume":"80","author":"LM Sherief","year":"2020","unstructured":"Sherief LM, et al. Screening for Hepatitis C Virus (HCV) Infection in Acute Lymphoblastic Leukemia (ALL) Survivors in The Hematology and Oncology Department of Children Hospital Zagazig University. Egyptian J Hosp Med. 2020;80:662\u20135.","journal-title":"Egyptian J Hosp Med"},{"key":"1878_CR23","doi-asserted-by":"publisher","first-page":"470","DOI":"10.21608\/ejhm.2022.213795","volume":"86","author":"S Mahrous","year":"2022","unstructured":"Mahrous S, et al. Seronegative and occult hepatitis C Virus infection in patients with acute and chronic myeloid leukemia. Egyptian J Hosp Med. 2022;86:470\u20136.","journal-title":"Egyptian J Hosp Med"},{"key":"1878_CR24","doi-asserted-by":"publisher","first-page":"6214","DOI":"10.3748\/wjg.v19.i37.6214","volume":"19","author":"A Elkady","year":"2013","unstructured":"Elkady A, et al. Incidence and characteristics of HBV reactivation in hematological malignant patients in south Egypt. World J Gastroenterol. 2013;19:6214.","journal-title":"World J Gastroenterol"},{"key":"1878_CR25","first-page":"349","volume":"162","author":"Z Zhang","year":"2017","unstructured":"Zhang Z, et al. High risk of occult hepatitis B virus infection in leukemia patients from China. Adv Virol. 2017;162:349\u201357.","journal-title":"Adv Virol"},{"key":"1878_CR26","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00277-010-1055-5","volume":"90","author":"J Kang","year":"2011","unstructured":"Kang J, et al. High prevalence of hepatitis B and hepatitis C virus infections in Korean patients with hematopoietic malignancies. Ann Hematol. 2011;90:159\u201364.","journal-title":"Ann Hematol"},{"key":"1878_CR27","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1002\/jmv.24916","volume":"90","author":"GK Nasrallah","year":"2018","unstructured":"Nasrallah GK, et al. Estimating seroprevalence of herpes simplex virus type 1 among different Middle East and North African male populations residing in Qatar. J Med Virol. 2018;90:184\u201390.","journal-title":"J Med Virol"},{"key":"1878_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.21608\/ejabf.2019.29237","volume":"23","author":"NI Ahmed","year":"2019","unstructured":"Ahmed NI, et al. Prevalence of human polyomavirus and papillomavirus in wastewater and in stool of Egyptian patients. Egyptian J Aquatic Biol Fisheries. 2019;23:29\u201341.","journal-title":"Egyptian J Aquatic Biol Fisheries"},{"key":"1878_CR29","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S1470-2045(08)70070-6","volume":"9","author":"C-H Pui","year":"2008","unstructured":"Pui C-H, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008;9:257\u201368.","journal-title":"Lancet Oncol"},{"key":"1878_CR30","first-page":"4674","volume":"9","author":"H Pfeifer","year":"2003","unstructured":"Pfeifer H, et al. Risk and prognosis of central nervous system leukemia in patients with Philadelphia chromosome-positive acute leukemias treated with imatinib mesylate. Clin Cancer Res. 2003;9:4674\u201381.","journal-title":"Clin Cancer Res"},{"key":"1878_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1182\/blood.V82.3.895.895","volume":"82","author":"C-H Pui","year":"1993","unstructured":"Pui C-H, et al. Serum intercellular adhesion molecule-1 in childhood malignancy. Blood. 1993;82:895\u20138.","journal-title":"Blood"},{"key":"1878_CR32","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.ejcb.2009.11.026","volume":"89","author":"JWJ van Kilsdonk","year":"2010","unstructured":"van Kilsdonk JWJ, et al. Soluble adhesion molecules in human cancers: sources and fates. Eur J Cell Biol. 2010;89:415\u201327.","journal-title":"Eur J Cell Biol"},{"key":"1878_CR33","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1177\/1010428318811525","volume":"40","author":"ICCFE Fonseca","year":"2018","unstructured":"Fonseca ICCFE, et al. Cell-adhesion molecules and their soluble forms: promising predictors of \u201ctumor progression\u201d and relapse in leukemia. Tumor Biol. 2018;40:525.","journal-title":"Tumor Biol"},{"key":"1878_CR34","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10723","volume":"9","author":"MP Ivelja","year":"2021","unstructured":"Ivelja MP, et al. Blood markers of endothelial dysfunction and their correlation to cerebrovascular reactivity in patients with chronic hepatitis C infection. PeerJ. 2021;9: e10723.","journal-title":"PeerJ"},{"key":"1878_CR35","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1023\/A:1018818801824","volume":"42","author":"G Kaplanski","year":"1997","unstructured":"Kaplanski G, et al. Increased levels of soluble adhesion molecules in the serum of patients with Hepatitis C (Correlation with Cytokine Concentrations and Liver Inflammation and Fibrosis). Dig Dis Sci. 1997;42:2277\u201384.","journal-title":"Dig Dis Sci"},{"key":"1878_CR36","first-page":"89","volume":"14","author":"OH Al-Jiffri","year":"2017","unstructured":"Al-Jiffri OH. Adhesive molecules and inflammatory markers a hepatitis C virus Saudi patients. European J General Med. 2017;14:89\u201393.","journal-title":"European J General Med"},{"key":"1878_CR37","doi-asserted-by":"publisher","first-page":"68","DOI":"10.21037\/atm-20-3140","volume":"9","author":"D Deak","year":"2021","unstructured":"Deak D, et al. A narrative review of central nervous system involvement in acute leukemias. Ann Transl Med. 2021;9:68.","journal-title":"Ann Transl Med"},{"key":"1878_CR38","first-page":"27","volume":"13","author":"GF Helaly","year":"2006","unstructured":"Helaly GF, Abou Shamaa LA. Influence of hepatitis c virus infection on circulating levels of slCAM-1 and VEGF in patients with hepatitis c and hepatocellular carcinoma (HCC) and their role in enhancing detection of HCC. Egyptian J Immunol. 2006;13:27\u201338.","journal-title":"Egyptian J Immunol"},{"key":"1878_CR39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1182\/blood-2017-03-769315","volume":"130","author":"V M\u00fcnch","year":"2017","unstructured":"M\u00fcnch V, et al. Central nervous system involvement in acute lymphoblastic leukemia is mediated by vascular endothelial growth factor. Blood. 2017;130:643\u201354.","journal-title":"Blood"},{"key":"1878_CR40","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MPG.0000000000001872","volume":"66","author":"G Indolfi","year":"2018","unstructured":"Indolfi G, et al. Treatment of chronic hepatitis C virus infection in children: a position paper by the Hepatology Committee of European Society of Paediatric Gastroenterology, Hepatology and Nutrition. J Pediatr Gastroenterol Nutr. 2018;66:505\u201315.","journal-title":"J Pediatr Gastroenterol Nutr"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-022-01878-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-022-01878-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T15:09:15Z","timestamp":1674745755000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-022-01878-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,25]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["1878"],"URL":"https:\/\/doi.org\/10.1007\/s15010-022-01878-9","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"type":"print","value":"0300-8126"},{"type":"electronic","value":"1439-0973"}],"subject":[],"published":{"date-parts":[[2022,7,25]]},"assertion":[{"value":"17 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no financial or personal relationships with other people or organizations that could inappropriately influence (bias) their work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}